Skip to main content
. 2025 Mar 12;23:22. doi: 10.1186/s12959-025-00708-w

Table 4.

Outcomes of patients

Variables All patients
N = 438
Peripheral PE
N = 305
Central PE
N = 133
P value
All-cause hospital mortality, N (%) 27 (6.2) 20 (6.6) 7 (5.3) 0.61
Pulmonary embolism-related hospital mortality, N (%) 16 (3.7) 10 (3.3) 6 (4.5) 0.58
Six-moth mortality, N (%) 69/379 (18.2) 51/269 (19.0) 18/110 (16.4) 0.55
Unable to assess six-month mortality due to follow-up loss (% of study patients) 59/438 (13.5) 36/305 (11.8) 23/133 (17.3) 0.13
Bleeding in a critical area or organ, N (%) 27 (6.2) 19 (6.2) 8 (6.0) 0.93
Intracranial bleeding, N (%) 7 (1.6) 5 (1.6) 2 (1.5) 0.92
Bleeding leading to blood transfusion, N (%) 19 (4.3) 13 (4.3) 6 (4.5) 0.91
Fatal bleeding, N (%) 8 (1.8) 5 (1.6) 3 (2.3) 0.66
ICU LOS (days) for patients who needed ICU admission, median (Q1, Q3) 4.0 (2.0, 10.5) 3.0 (7.0, 12.0) 3.0 (2.0, 6.5) 0.01**
Hospital LOS (days), median (Q1, Q3) 6.0 (3.0, 11.0) 5.0 (3.0, 11.0) 7.0 (4.0, 11.0) 0.03**

ICU Intensive care unit, LOS Length of stay, MV Mechanical ventilation, Q1 First quartile, Q3 Third quartile, RRT Renal replacement therapy, VTE Venous thromboembolism

*Student t test

** Mann–Whitney U test